Fred Kurland
Geen lopende functies
Vermogen: 312 $ op 31-03-2024
Loopbaan van Fred Kurland
Eerdere bekende functies van Fred Kurland
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ARIDIS PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 11-06-2021 | - |
Director of Finance/CFO | 11-06-2021 | 04-08-2023 | |
ARIDIS PHARMACEUTICALS, INC. | Director of Finance/CFO | 14-07-2015 | 31-12-2019 |
XOMA CORPORATION | Director of Finance/CFO | 28-12-2008 | 03-04-2015 |
Corporate Secretary | 28-12-2008 | 03-04-2015 | |
Bayhill Therapeutics, Inc.
Bayhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bayhill Therapeutics, Inc. develops and commercializes therapeutics. Its technology is BHT-DNA. The firm is a clinical-stage biopharmaceutical company leveraging its proprietary therapeutic BHT-DNA platform to develop a pipeline of novel and targeted treatment candidates for autoimmune diseases. Bayhill Therapeutics was founded by Lawrence Steinman, Hideki Garren, William H. Robinson and Paul J. Utz in 2001 and is headquartered in Palo Alto, CA. | Director of Finance/CFO | 01-05-2007 | - |
CORCEPT THERAPEUTICS INCORPORATED | Director of Finance/CFO | 01-01-2004 | 13-04-2007 |
GENITOPE CORPORATION | Director of Finance/CFO | 01-01-2002 | 01-01-2004 |
MedImmune Vaccines, Inc.
MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA | Director of Finance/CFO | 01-01-1998 | 01-01-2002 |
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | Director of Finance/CFO | 01-01-1996 | 01-01-1998 |
Applied Immune Sciences, Inc.
Applied Immune Sciences, Inc. Medical SpecialtiesHealth Technology Part of Sanofi, Applied Immune Sciences, Inc. is a surgical and medical instruments company. The private company is based in Menlo Park, CA. The company was founded by Thomas B. Okarma. Applied Immune Sciences was acquired by Rhone-Poulenc Rorer, Inc. on November 28, 1995 for $84.40 million. | Director of Finance/CFO | 01-01-1995 | 01-01-1996 |
░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Fred Kurland
The University of Chicago | Graduate Degree |
Lehigh University | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 12 |
Operationeel
Director of Finance/CFO | 9 |
Comptroller/Controller/Auditor | 2 |
Undergraduate Degree | 1 |
Sectoraal
Health Technology | 10 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
XOMA CORPORATION | Health Technology |
CORCEPT THERAPEUTICS INCORPORATED | Health Technology |
ARIDIS PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
Applied Immune Sciences, Inc.
Applied Immune Sciences, Inc. Medical SpecialtiesHealth Technology Part of Sanofi, Applied Immune Sciences, Inc. is a surgical and medical instruments company. The private company is based in Menlo Park, CA. The company was founded by Thomas B. Okarma. Applied Immune Sciences was acquired by Rhone-Poulenc Rorer, Inc. on November 28, 1995 for $84.40 million. | Health Technology |
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | Health Technology |
Syntex Corp. | Health Technology |
MedImmune Vaccines, Inc.
MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA | Health Technology |
Genitope Corp.
Genitope Corp. BiotechnologyHealth Technology Genitope Corp. operates as a biotechnology company, which focuses on the research and development of novel immunotherapies for the treatment of cancer. The company was founded on August 15, 1996 and is headquartered in Redwood, CA. | Health Technology |
Bayhill Therapeutics, Inc.
Bayhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bayhill Therapeutics, Inc. develops and commercializes therapeutics. Its technology is BHT-DNA. The firm is a clinical-stage biopharmaceutical company leveraging its proprietary therapeutic BHT-DNA platform to develop a pipeline of novel and targeted treatment candidates for autoimmune diseases. Bayhill Therapeutics was founded by Lawrence Steinman, Hideki Garren, William H. Robinson and Paul J. Utz in 2001 and is headquartered in Palo Alto, CA. | Health Technology |
- Beurs
- Insiders
- Fred Kurland
- Ervaring